Metabolic fingerprinting in toxicological assessment using FT-ICR MS

Journal of Toxicologic Pathology

Volumn 23, Issue 2, 2010, Pages 67-74

  Hasegawa, Mina ^a   Ide, Mika ^b   Kuwamura, Mitsuru ^a   Yamate, Jyoji ^a   Takenaka, Shigeo ^a  

^a Osaka Prefecture University   (Japan)

^b MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

FT ICR MS; Metabolic fingerprinting; Metabolomics; MS; NMR; Toxicological assessment

Indexed keywords

1 NAPHTHYL ISOTHIOCYANATE; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; AMIODARONE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BIOLOGICAL MARKER; FLUOXETINE; GENTAMICIN; HIPPURIC ACID; INDICAN; PERHEXILINE; THIOACETAMIDE;

BILE DUCT DISEASE; BIOCHEMISTRY; DRUG URINE LEVEL; HISTOPATHOLOGY; HUMAN; INTRAHEPATIC CHOLESTASIS; ION CYCLOTRON RESONANCE MASS SPECTROMETRY; LIPIDOSIS; LIVER NECROSIS; LIVER TOXICITY; METABOLITE; METABOLOME; METABOLOMICS; NONHUMAN; REVIEW; TOXICITY TESTING;

EID: 77957083778     PISSN: 09149198     EISSN: None     Source Type: Journal    
DOI: 10.1293/tox.23.67     Document Type: Review

References (30)

1. Colebatch G, Trevaskis B, and Udvardi M. Functional genomics: tools of the trade. New Phytol. 153: 27-36. 2002.
2. Goodacre R, Vaidyanathan S, Dunn WB, Harrigan GG, and Kell DB. Metabolomics by numbers: acquiring and understanding global metabolite data. Trends Biotechnol. 22: 245-252. 2004.
3. Hellerstein MK. New stable isotope-mass spectrometric techniques for measuring fluxes through intact metabolic pathways in mammalian systems: introduction of moving pictures into functional genomics and biochemical phenotyping. Metab Eng. 6: 85-100. 2004.
4. Kell DB, Brown M, Davey HM, Dunn WB, Spasic I, and Oliver SG. Metabolic footprinting and systems biology: the medium is the message. Nat Rev Microbiol. 3: 557-565. 2005.
5. Lahner B, Gong J, Mahmoudian M, Smith EL, Abid KB, Rogers EE, Guerinot ML, Harper JF, Ward JM, McIntyre L, Schroeder JI, and Salt DE. Genomic scale profiling of nutrient and trace elements in Arabidopsis thaliana. Nat Biotechnol. 21: 1215-1221. 2003.
6. Fiehn O. Metabolomics-the link between genotypes and phenotypes. Plant Mol Biol. 48: 155-171. 2002.
7. Tanaka K, Hine DG, West-Dull A, and Lynn TB. Gaschromatographic method of analysis for urinary organic acids. I. Retention indices of 155 metabolically important compounds. Clin Chem. 26: 1839-1846. 1980.
8. Lindon JC, Keun HC, Ebbels TM, Pearce JM, Holmes E, and Nicholson JK. The Consortium for Metabonomic Toxicology (COMET): aims, activities and achievements. Pharmacogenomics. 6: 691-699. 2005.
9. Bollard ME, Keun HC, Beckonert O, Ebbels TM, Antti H, Nicholls AW, Shockcor JP, Cantor GH, Stevens G, Lindon JC, Holmes E, and Nicholson JK. Comparative metabonomics of differential hydrazine toxicity in the rat and mouse. Toxicol Appl Pharmacol. 204: 135-151. 2005.
10. Coen M, Holmes E, Lindon JC, and Nicholson JK. NMRbased metabolic profiling and metabonomic approaches to problems in molecular toxicology. Chem Res Toxicol. 21: 9-27. 2008.
11. Brown SC, Kruppa G, and Dasseux JL. Metabolomics applications of FT-ICR mass spectrometry. Mass Spectrom Rev. 24: 223-231. 2005.
12. Marshall AG, Hendrickson CL, and Jackson GS. Fourier transform ion cyclotron resonance mass spectrometry: A primer. Mass Spectrom Rev. 17: 1-35, 1998
13. Aharoni A, Ric de Vos CH, Verhoeven HA, Maliepaard CA, Kruppa G, Bino R, and Goodenowe DB. Nontargeted metabolome analysis by use of Fourier transform ion cyclotron mass spectrometry. OMICS. 6: 217-234. 2002.
14. Hasegawa M, Takenaka S, Kuwamura M, Yamate J, and Tsuyama S. Urinary metabolic fingerprinting for amiodarone-induced phospholipidosis in rats using FT-ICR MS. Exp Toxicol Pathol. 59: 115-120. 2007.
15. Halliwell WH. Cationic amphiphilic drug-induced phospholipidosis. Toxicol Pathol. 25: 53-60. 1997.
16. Hook GE. Alveolar proteinosis and phospholipidoses of the lungs. Toxicol Pathol. 19: 482-513. 1991.
17. James MO, Smith RL, Williams RT, and Reidenberg M. The conjugation of phenylacetic acid in man, sub-human primates and some non-primate species. Proc R Soc Lond B Biol Sci. 182: 25-35. 1972.
18. Nicholls AW, Nicholson JK, Haselden JN, and Waterfield CJ. A metabonomic approach to the investigation of druginduced phospholipidosis: an NMR spectroscopy and pattern recognition study. Biomarkers. 5: 410-423. 2000.
19. Idborg-Bjorkman H, Edlund PO, Kvalheim OM, Schuppe-Koistinen I, and Jacobsson SP. Screening of biomarkers in rat urine using LC/electrospray ionization-MS and two-way data analysis. Anal Chem. 75: 4784-4792. 2003.
20. Delaney J, Neville WA, Swain A, Miles A, Leonard MS, and Waterfield CJ. Phenylacetylglycine, a putative biomarker of phospholipidosis: its origins and relevance to phospholipid accumulation using amiodarone treated rats as a model. Biomarkers. 9: 271-290. 2004.
21. Dieterle F, Ross A, Schlotterbeck G, and Senn H. Metabolite projection analysis for fast identification of metabolites in metabonomics. Application in an amiodarone study. Anal Chem. 78: 3551-3561. 2006.
22. Nicholls AW, Mortishire-Smith RJ, and Nicholson JK. NMR spectroscopic-based metabonomic studies of urinary metabolite variation in acclimatizing germ-free rats. Chem Res Toxicol. 16: 1395-1404. 2003.
23. Connor SC, Wu W, Sweatman BC, Manini J, Haselden JN, Crowther DJ, and Waterfield CJ. Effects of feeding and body weight loss on the 1H-NMR-based urine metabolic profiles of male Wistar Han rats: implications for biomarker discovery. Biomarkers. 9: 156-179. 2004.
24. Hasegawa M, Ide M, Takenaka S, Yamate J, and Tsuyama S. Urinary metabolic fingerprinting for thioacetamide-induced rat acute hepatic injury using Fourier transform-ion cyclotron resonance mass spectrometry (FT-ICR MS), with reference to detection of potential biomarkers for hepatotoxicity. Toxicol Pathol. 35: 570-575. 2007.
25. Hasegawa M, Ide M, Fujita T, and Takenaka S. Urinary metabolic fingerprinting for alpha-naphthylisothiocyanate induced intrahepatic cholestasis in rats using Fourier transform-ion cyclotron resonance mass spectrometry. Toxicol Pathol. 36: 818-826. 2008.
26. La S, Yoo HH, and Kim DH. Liquid chromatography-mass spectrometric analysis of urinary metabolites and their pattern recognition for the prediction of drug-induced hepatotoxicity. Chem Res Toxicol. 18: 1887-1896. 2005.
27. Chan TS, Lakhchaura BD, and Hsu TF. Differences in deoxycytidine metabolism in mouse and rat. Biochem J. 210: 367-371. 1983.
28. Ide M, Yamate J, Machida Y, Nakanishi M, Kuwamura M, Kotani T, and Sawamoto O. Emergence of different macrophage populations in hepatic fibrosis following thioacetamide-induced acute hepatocyte injury in rats. J Comp Pathol. 128: 41-51. 2003.
29. Robertson DG, Reily MD, Sigler RE, Wells DF, Paterson DA, and Braden TK. Metabonomics: evaluation of nuclear magnetic resonance (NMR) and pattern recognition technology for rapid in vivo screening of liver and kidney toxicants. Toxicol Sci. 57: 326-337. 2000.
30. Azmi J, Griffin JL, Shore RF, Holmes E, and Nicholson JK. Chemometric analysis of biofluids following toxicant induced hepatotoxicity: a metabonomic approach to distinguish the effects of 1-naphthylisothiocyanate from its products. Xenobiotica. 35: 839-852. 2005.